Resmed (RMD)
NYSE:RMD
Holding RMD?
Track your performance easily

Resmed (RMD) Financial Statements

959 Followers

Resmed Financial Overview

Resmed's market cap is currently ―. The company's EPS TTM is $6.921; its P/E ratio is 36.39; and it has a dividend yield of 0.79%. Resmed is scheduled to report earnings on October 24, 2024, and the estimated EPS forecast is $2.06. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 1.22B$ 1.16B$ 1.10B$ 624.08M$ 1.12B
Gross Profit$ 715.53M$ 646.93M$ 600.06M$ -342.16M$ 1.12B
EBIT$ 298.42M$ 273.26M$ 287.15M$ 324.18M$ 289.38M
EBITDA$ 353.17M$ 326.63M$ 340.59M$ 379.38M$ 342.17M
Net Income Common Stockholders$ 292.24M$ 231.95M$ 244.38M$ 229.66M$ 232.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 238.36M$ 210.25M$ 209.10M$ 227.89M$ 227.89M
Total Assets$ 6.87B$ 6.91B$ 6.74B$ 6.75B$ 6.71B
Total Debt$ 873.93M$ 1.39B$ 1.50B$ 1.58B$ 1.72B
Net Debt$ 635.57M$ 1.18B$ 1.29B$ 1.35B$ 1.50B
Total Liabilities$ 2.01B$ 2.42B$ 2.49B$ 2.62B$ 2.78B
Stockholders Equity$ 4.86B$ 4.48B$ 4.25B$ 4.13B$ 3.93B
Cash Flow-
Free Cash Flow$ 413.79M$ 248.27M$ 245.42M$ 198.72M$ 251.34M
Operating Cash Flow$ 440.11M$ 272.83M$ 286.28M$ 237.46M$ 282.56M
Investing Cash Flow$ -46.51M$ -41.14M$ -148.98M$ -46.52M$ -28.10M
Financing Cash Flow$ -393.28M$ -238.96M$ -151.13M$ -188.59M$ -279.56M
Currency in USD

Resmed Earnings and Revenue History

Resmed Debt to Assets

Resmed Cash Flow

Resmed Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis